1,2-dipalmitoylphosphatidylcholine has been researched along with Lung Diseases in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agudelo, CW; Garcia-Arcos, I; Samaha, G | 1 |
| Chai, X; Huang, J; Li, Y; Ning, P; Tian, S; Xu, L; Zhang, L; Zhao, Q | 1 |
| Huang, W; Lewis, JF; McCaig, LA; Veldhuizen, RA; Yao, LJ | 1 |
| Henderson, F; Mallampalli, RK; McCoy, DM; McGowan, SE; Salome, RG; Wu, Y; Zhou, J | 1 |
| Ashton, MR; Hall, MA; Postle, AD; Smith, DE | 1 |
| Akino, T; Hattori, A; Kuroki, Y; Sohma, H | 1 |
| Inchley, K; Lewis, JF; Maitra, G; Novick, RJ; Possmayer, F; Veldhuizen, RA | 1 |
| Korfhagen, TR; Quintero, OA; Wright, JR | 1 |
| Hepworth, SR; Shek, PN; Suntres, ZE | 1 |
| Ashton, MR; Hall, MA; Kelly, FJ; Normand, IC; Postle, AD; Smith, SL | 1 |
1 review(s) available for 1,2-dipalmitoylphosphatidylcholine and Lung Diseases
| Article | Year |
|---|---|
Alveolar lipids in pulmonary disease. A review.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Humans; Lipid Metabolism; Lung; Lung Diseases; Macrophages, Alveolar; Pulmonary Alveoli; Pulmonary Surfactants; Respiratory Distress Syndrome | 2020 |
1 trial(s) available for 1,2-dipalmitoylphosphatidylcholine and Lung Diseases
| Article | Year |
|---|---|
Surfactant phosphatidylcholine composition during dexamethasone treatment in chronic lung disease.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Analysis of Variance; Chronic Disease; Dexamethasone; Double-Blind Method; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Lung Diseases; Phosphatidylcholines; Pulmonary Surfactants; Time Factors | 1994 |
8 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Lung Diseases
| Article | Year |
|---|---|
Interaction of inhalable volatile organic compounds and pulmonary surfactant: Potential hazards of VOCs exposure to lung.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Environmental Exposure; Environmental Monitoring; Lung; Lung Diseases; Microscopy, Atomic Force; Phospholipids; Pulmonary Surfactants; Serum Albumin; Solubility; Swine; Thermodynamics; Volatile Organic Compounds | 2019 |
Mechanisms responsible for surfactant changes in sepsis-induced lung injury.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Analysis of Variance; Animals; Disease Models, Animal; Lipid Metabolism; Lung Diseases; Macrophages; Male; Probability; Pulmonary Surfactant-Associated Proteins; Pulmonary Surfactants; Rats; Rats, Sprague-Dawley; Risk Factors; Sensitivity and Specificity; Sepsis | 2005 |
Adenoviral gene transfer of a mutant surfactant enzyme ameliorates pseudomonas-induced lung injury.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Acute Disease; Adenoviridae; Animals; Calcium-Binding Proteins; Choline-Phosphate Cytidylyltransferase; Genetic Therapy; Genetic Vectors; Lung; Lung Diseases; Male; Mice; Mice, Inbred C57BL; Pseudomonas Infections; Pulmonary Surfactants; Transduction, Genetic | 2006 |
Calcium and dithiothreitol dependent conformational changes in beta-sheet structure of collagenase resistant fragment of human surfactant protein A.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Biological Transport; Bronchoalveolar Lavage Fluid; Calcium; Circular Dichroism; Collagenases; Dithiothreitol; Edetic Acid; Glycoproteins; Humans; Kinetics; Liposomes; Lung Diseases; Male; Peptide Fragments; Phosphatidylcholines; Phosphatidylglycerols; Protein Structure, Secondary; Proteolipids; Pulmonary Alveoli; Pulmonary Surfactant-Associated Protein A; Pulmonary Surfactant-Associated Proteins; Pulmonary Surfactants; Rats; Rats, Sprague-Dawley | 1993 |
Acute lung injury and lung transplantation influence in vitro subtype conversion of pulmonary surfactant.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Acute Disease; Animals; Dogs; Enzyme Inhibitors; Hyperventilation; Ischemia; Lipids; Lung Diseases; Lung Transplantation; Phenylmethylsulfonyl Fluoride; Protein Isoforms; Pulmonary Circulation; Pulmonary Surfactants; Reference Values | 2002 |
Surfactant protein A regulates surfactant phospholipid clearance after LPS-induced injury in vivo.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Choline; Homeostasis; Lipopolysaccharides; Liposomes; Lung Diseases; Mice; Mice, Knockout; Palmitates; Proteolipids; Pulmonary Alveoli; Pulmonary Surfactant-Associated Protein A; Pulmonary Surfactant-Associated Proteins; Pulmonary Surfactants; Tritium | 2002 |
Protective effect of liposome-associated alpha-tocopherol against paraquat-induced acute lung toxicity.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Body Weight; Cytochrome P-450 Enzyme System; Drug Administration Routes; Drug Carriers; Glutathione; Glutathione Disulfide; Lipid Peroxidation; Liposomes; Lung; Lung Diseases; Male; Membrane Lipids; Organ Size; Paraquat; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Trachea; Vitamin E | 1992 |
Phosphatidylcholine composition of endotracheal tube aspirates of neonates and subsequent respiratory disease.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Chromatography, High Pressure Liquid; Chronic Disease; Gestational Age; Humans; Infant; Infant, Newborn; Intubation, Intratracheal; Lung Diseases; Phosphatidylcholines; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1992 |